Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts - PubMed (original) (raw)

. 1992 Mar;140(3):739-47.

Affiliations

• PMID: 1312309
• PMCID: PMC1886167

Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts

T C Wu et al. Am J Pathol. 1992 Mar.

Abstract

Cytomegalovirus (CMV) infection has been associated with the development of accelerated arteriosclerosis in heart transplant recipients. This association prompted the authors to examine, using in situ hybridization techniques, the coronary arteries of 19 patients who had received heart transplants for the presence of CMV nucleic acids. Two probes were employed on formalin-fixed paraffin-embedded tissues. The first was an S35-labeled nick translated probe derived from CMV DNA. CMV nucleic acids were identified in the arterial intima of 5 (45%) of 11 transplanted hearts examined with this probe. Hybridization to cells morphologically consistent with endothelial cells, lymphocytes, and smooth muscle cells was identified. Hybridization was not detected in any of the hearts when a control probe, a vector without CMV DNA, was employed. The second probe that was used was a tritium-labeled strand-specific ribo-probe derived from the immediate early (IE1) gene of CMV. Using this second probe, hybridization was detected in the coronary arteries of three of five hearts that were positive with the DNA probe, in one of the hearts that was negative with the DNA probe, and in three (38%) of eight additional transplanted hearts. The pattern of hybridization was the same as that seen with the DNA probe, and no hybridization was detected when a control sense probe for the IE1 gene of CMV was employed. These results suggest that CMV nucleic acids are present in the coronary arteries of heart transplant recipients.

PubMed Disclaimer

Similar articles

• The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients.
  Hendrix MG, Dormans PH, Kitslaar P, Bosman F, Bruggeman CA. Hendrix MG, et al. Am J Pathol. 1989 May;134(5):1151-7. Am J Pathol. 1989. PMID: 2541613 Free PMC article.
• The WAF1-mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipients.
  Baas IO, Offerhaus JA, El-Deiry WS, Wu TC, Hutchins GM, Kasper EK, Baughman KL, Baumgartner WA, Chiou CJ, Hayward GS, Hruban RH. Baas IO, et al. Hum Pathol. 1996 Apr;27(4):324-9. doi: 10.1016/s0046-8177(96)90103-3. Hum Pathol. 1996. PMID: 8617473
• Absence of association between cytomegalovirus infection and obliterative transplant arteriopathy in renal allograft rejection.
  Nadasdy T, Smith J, Laszik Z, Waner JL, Johnson LD, Silva FG. Nadasdy T, et al. Mod Pathol. 1994 Apr;7(3):289-94. Mod Pathol. 1994. PMID: 8058700
• [Cytomegalovirus associated diseases of the heart].
  Schönian U, Maisch B. Schönian U, et al. Herz. 1992 Apr;17(2):85-90. Herz. 1992. PMID: 1315712 German.
• Cytomegalovirus infection and atherosclerosis.
  Adam E, Melnick JL, DeBakey ME. Adam E, et al. Cent Eur J Public Health. 1997 Sep;5(3):99-106. Cent Eur J Public Health. 1997. PMID: 9386894 Review.

Cited by

• Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells.
  Yaiw KC, Mohammad AA, Taher C, Cui HL, Costa H, Kostopoulou ON, Jung M, Assinger A, Wilhelmi V, Yang J, Strååt K, Rahbar A, Pernow J, Söderberg-Nauclér C. Yaiw KC, et al. Microorganisms. 2021 May 25;9(6):1137. doi: 10.3390/microorganisms9061137. Microorganisms. 2021. PMID: 34070407 Free PMC article.
• Antiviral anticoagulation.
  Pryzdial ELG, Sutherland MR, Lin BH, Horwitz M. Pryzdial ELG, et al. Res Pract Thromb Haemost. 2020 Jul 6;4(5):774-788. doi: 10.1002/rth2.12406. eCollection 2020 Jul. Res Pract Thromb Haemost. 2020. PMID: 32685886 Free PMC article. Review.
• Macrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization.
  Cousins SW, Espinosa-Heidmann DG, Miller DM, Pereira-Simon S, Hernandez EP, Chien H, Meier-Jewett C, Dix RD. Cousins SW, et al. PLoS Pathog. 2012;8(4):e1002671. doi: 10.1371/journal.ppat.1002671. Epub 2012 Apr 26. PLoS Pathog. 2012. PMID: 22570607 Free PMC article.
• Human cytomegalovirus infection and atherothrombosis.
  Popović M, Smiljanić K, Dobutović B, Syrovets T, Simmet T, Isenović ER. Popović M, et al. J Thromb Thrombolysis. 2012 Feb;33(2):160-72. doi: 10.1007/s11239-011-0662-x. J Thromb Thrombolysis. 2012. PMID: 22161772 Review.
• Cytomegalovirus-induced immunopathology and its clinical consequences.
  Varani S, Landini MP. Varani S, et al. Herpesviridae. 2011 Apr 7;2(1):6. doi: 10.1186/2042-4280-2-6. Herpesviridae. 2011. PMID: 21473750 Free PMC article.

References

1. 1. Science. 1985 Nov 29;230(4729):1048-51 - PubMed
2. 1. Am J Pathol. 1986 Jan;122(1):62-70 - PubMed
3. 1. J Virol. 1985 Dec;56(3):839-45 - PubMed
4. 1. N Engl J Med. 1986 May 29;314(22):1418-23 - PubMed
5. 1. Transplantation. 1986 Oct;42(4):364-7 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information